Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model.
Zhang, Xuefeng, Eric Galardi, Mark Duquette, Jack Lawler, and Sareh Parangi. 2005. “Antiangiogenic Treatment With Three Thrombospondin-1 Type 1 Repeats versus Gemcitabine in an Orthotopic Human Pancreatic Cancer Model.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 11 (15): 5622-30.